Home
Conditions
Urologic Neoplasms

Clinical trial condition

Urologic Neoplasms

Explore clinical trials studying Urologic Neoplasms. Study availability and eligibility vary by location and protocol.

2,952 public trials 630 recruiting studies

Refine in advanced search Browse all conditions

Urologic Neoplasms trial results

Not Yet Recruiting

Evaluation of the Clinical Utility of Online Adaptive Radiotherapy in Bladder Cancer (BLADAPT-GETUG V11)

NCT07043543

Conditions: Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations: Centre Georges François Leclerc Dijon, Côte d'or, France

Institut du Cancer de Montpellier Montpellier, Herault, France

Centre Eugène Marquis Rennes, Ille et Vilaine, France

Institut de Cancérologie de l'Ouest Saint-Herblain, Loire Atlantique, France

View Trial Details

Not Yet Recruiting

Iparomlimab and Tuvonralimab Injection in Combination With Lenvatinib or Axitinib for the Treatment of Locally Advanced or Metastatic Clear Cell Renal Cell Carcinoma That Has Failed First-Line Systemic Therapy

NCT07277972

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

A Phase III Randomised Control Clinical Trial of Radiotherapy With Radiosensitisation Versus Intravesical Bacillus Calmette-Guerin Therapy for High-risk Non-muscle Invasive Bladder Cancer.

NCT07268339

Conditions: Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
Locations: The Christie Manchester, United Kingdom

View Trial Details

Not Yet Recruiting

Entinostat & Chemotherapy for Locally Advanced or Metastatic Bladder Cancer

NCT07261592

Conditions: Bladder Cancer, Chemotherapy, Entinostat, +12 more
Locations: Department of Urology, Drum Tower Hospital, Medical School of Nanjing University, Institute of Urology, Nanjing University Nanjing, Jiangsu, China

View Trial Details

Not Yet Recruiting

Immediate Versus Deferred Cytoreductive Nephrectomy With Ipilimumab/Nivolumab in mRCC

NCT07233668

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

The Combined Role of FAPI PET and Liquid Biopsy in the Staging and Clinical Management of Bladder Cancer - FUTURE Trial

NCT07257718

Conditions: Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

A Clinical Trial of Envafolimab Combined With Lenvatinib for Kidney Cancer With Liver Spread

NCT07256223

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +15 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Study of ACC-1898 in Adult Participants With Advanced Solid Tumors

NCT07252661

Conditions: Adenocarcinoma, Advanced Solid Tumor, Biliary Tract Diseases, +44 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Neutrophil Biomarker Test for Predicting Clinical Benefit From Immunotherapy Based on Flow Cytometry Analysis

NCT07246759

Conditions: Adenocarcinoma, Breast Diseases, Breast Neoplasms, +41 more
Locations: Heidelberg University Hospital Heidelberg, Germany

Intituto Europeo di Oncologia SRL Milan, Italy

Virgen Macarena University Hospital - Servicio Andaluz de Salud Seville, Spain

View Trial Details

Not Yet Recruiting

RP2 and Tivozanib for the Treatment of Metastatic Renal Cell Cancer After Progression on Immunotherapy

NCT07218692

Conditions: Adenocarcinoma, Advanced Clear Cell Renal Cell Carcinoma, Advanced Renal Cell Carcinoma, +23 more
Locations: City of Hope Medical Center Duarte, California, United States

City of Hope at Irvine Lennar Irvine, California, United States

View Trial Details

Urologic Neoplasms

Urologic Neoplasms trial results

Related conditions